Cargando…

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE

Detalles Bibliográficos
Autores principales:	Ricciuto, Amanda, Lamb, Christopher, Kuenzig, Ellen, Griffiths, Anne M., Kaplan, Gilaad, Walker, Gareth J., Kennedy, Nick, Benchimol, Eric, Sebastian, Shaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2021
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108199/ http://dx.doi.org/10.1016/S0016-5085(21)01514-6

Ejemplares similares

Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
por: Dahiya, Monica, et al.
Publicado: (2021)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.
por: Olayinka, Lily, et al.
Publicado: (2021)

Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS
por: Sperger, John, et al.
Publicado: (2021)

Fr228 AN INTERNATIONAL REPORTING REGISTRY OF PATIENTS WITH CELIAC DISEASE AND COVID-19: INITIAL RESULTS FROM SECURE-CELIAC
por: Uche-Anya, Eugenia, et al.
Publicado: (2021)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
por: Agrawal, Manasi, et al.
Publicado: (2021)

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB
por: Alexander, James L., et al.
Publicado: (2022)

Fr195 PERCEPTIONS OF COVID-19 IN THE EOSINOPHILIC ESOPHAGITIS POPULATION
por: Thanawala, Shivani U., et al.
Publicado: (2021)

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Fr090 IMPACT OF THE COVID-19 PANDEMIC ON ENDOSCOPY CANCELLATIONS
por: Wang, Connie W., et al.
Publicado: (2021)

Fr002 EFFECT OF THE COVID-19 PANDEMIC ON ACUTE GASTROINTESTINAL BLEEDING
por: Reddy, Sumana, et al.
Publicado: (2021)

Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
por: Livanos, Alexandra E., et al.
Publicado: (2021)

Fr094 UTILITY OF COVID-19 ANTIBODY TESTING FOR PRE-ENDOSCOPY SCREENING
por: Noorali, Anika, et al.
Publicado: (2021)

Fr096 PERCEPTIONS OF TELEMEDICINE OFFICE VISITS DURING THE COVID-19 PANDEMIC
por: Foliente, Ethan, et al.
Publicado: (2021)

Fr501 BIOLOGICS AND COVID-19 OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Weissman, Simcha, et al.
Publicado: (2021)

855 PATIENT-LED REMOTE INTRACAPILLARY PHARMACOKINETIC SAMPLING (FINGERPRICKS): VALIDATION AND ACCEPTABILITY FOR HOME THERAPEUTIC DRUG MONITORING IN PATIENTS WITH IBD IN THE COVID-19 PANDEMIC
por: Chee, Desmond, et al.
Publicado: (2021)

Fr580 THE MICROBIOME AND SARS-COV-2: DAVID VERSUS A TINY GOLIATH
por: Hazan, Sabine, et al.
Publicado: (2021)

Fr230 EFFECT ON EARLY GROWTH OF OFFSPRING BY UNDIAGNOSED MATERNAL CELIAC DISEASE IN PREGNANCY
por: Choung, Rok Seon, et al.
Publicado: (2021)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE
por: Elli, Luca, et al.
Publicado: (2021)

Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19
por: Jha, Divya, et al.
Publicado: (2021)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr500 COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Fr502 INFLAMMATORY BOWEL DISEASE AND COVID-19: A LARGE INTEGRATED HEALTHCARE EXPERIENCE
por: Tashjian, Vartan C., et al.
Publicado: (2021)

Fr005 SEVERE COVID-19 ASSOCIATED WITH INCREASED RISK OF GI BLEEDING DURING HOSPITALIZATION
por: Alvencar, Sujay, et al.
Publicado: (2021)

Fr100 TELEMEDICINE IN GASTROENTEROLOGY: A STUDY ON FEASIBILITY AND PATIENTS’ TRUST DURING COVID-19 PANDEMIC.
por: Costantino, Andrea, et al.
Publicado: (2021)

Fr015 FACTORS RELATED TO NEW ONSET DYSPEPSIA AFTER COVID 19 INFECTION IN MEXICAN POPULATION
por: Rendon, Ricardo Flores, et al.
Publicado: (2021)

Fr012 THE OBSERVED RISK OF RECURRENT BLEEDING AND THROMBOEMBOLIC DISEASE IN COVID-19 PATIENTS WITH GASTROINTESTINAL BLEEDING.
por: Attah, Emmanuel O., et al.
Publicado: (2021)

Mo1087: MALADAPTIVE BEHAVIORS IN PERSONS WITH IBD DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Fr402 MELD-NA SCORE VERSUS SOFA SCORE AND APACHE II SCORE AS EARLY PREDICTORS OF MORTALITY IN COVID-19 PATIENTS WITH LIVER INVOLVEMENT
por: Gomez, Sandra R., et al.
Publicado: (2021)

Fr089 IMPACT OF COVID-19 ON PANDEMIC MAJOR GASTROENTEROLOGY PROCEDURES, VISITS, AND NEW DIAGNOSIS OF GASTROINTESTINAL CANCERS
por: Khan, Ahmad, et al.
Publicado: (2021)

Fr001 PROTON PUMP INHIBITOR AND RISK OF SARS-COV-2 INFECTION: A MULTI-CENTER EXPERIENCE
por: Silverman, Anna L., et al.
Publicado: (2021)

Fr104 ASSOCIATION OF GASTROINTESTINAL SYMPTOMS WITH OUTCOMES IN COVID-19 HOSPITALIZATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
por: Mehta, Deep, et al.
Publicado: (2021)

Fr007 GASTROINTESTINAL MANIFESTATIONS OF COVID-19 ACROSS THE UNITED STATES: A MULTI-CENTER COHORT STUDY
por: Patel, Ankur, et al.
Publicado: (2021)

Fr229 THE ASSOCIATION BETWEEN MALADAPTIVE EATING BEHAVIORS, SOCIAL ANXIETY, AND QUALITY OF LIFE IN ADULTS WITH CELIAC DISEASE.
por: Lee, Anne R., et al.
Publicado: (2021)

Fr578 ORAL TANNINS REDUCE PROINFLAMMATORY CYTOKINES ASSOCIATED WITH DIARRHEA AND PNEUMONIA IN HOSPITALIZED COVID-19 PATIENTS.
por: Pisarevsky, Ana A., et al.
Publicado: (2021)

Sa504 INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SOUTH ASIAN AND CHINESE PEOPLE: A POPULATION-BASED COHORT STUDY FROM ONTARIO, CANADA
por: Dhaliwal, Jasbir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bbftpjtgf63s01ij9t30smq4uo